| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $56.28 ▲ +1.33% | Yesterday | $55.23 ▼ -0.56% | Tomorrow's CRISPR Therapeutics AG Common Shares (CRSP) setup is anchored to $55.54 and targets $56.28 (+1.33%). The near-term read is upside; watch $57.21 / $53.87 because daily realized volatility is about 6.84%. |
Tomorrow's CRISPR Therapeutics AG Common Shares (CRSP) setup is anchored to $55.54 and targets $56.28 (+1.33%). The near-term read is upside; watch $57.21 / $53.87 because daily realized volatility is about 6.84%. | ||||
| Week | $57.83 ▲ +4.12% | Last Week | $54.58 ▼ -1.73% | The 7-day CRISPR Therapeutics AG Common Shares model moves from $54.58 to $57.83 (+4.12%). It gives upside momentum context for this stock, so breaks around $57.21 / $53.87 matter more than a single tick. |
The 7-day CRISPR Therapeutics AG Common Shares model moves from $54.58 to $57.83 (+4.12%). It gives upside momentum context for this stock, so breaks around $57.21 / $53.87 matter more than a single tick. | ||||
| Month | $60.42 ▲ +8.79% | Last Month | $53.49 ▼ -3.69% | The 1-month CRISPR Therapeutics AG Common Shares target is $60.42 (+8.79%), compared with the live reference near $55.54. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month CRISPR Therapeutics AG Common Shares target is $60.42 (+8.79%), compared with the live reference near $55.54. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $64.30 ▲ +15.77% | Last Year | $51.86 ▼ -6.62% | The 1-year CRISPR Therapeutics AG Common Shares scenario points to $64.30 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year CRISPR Therapeutics AG Common Shares scenario points to $64.30 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $73.39 ▲ +32.14% | 5 Years Ago | $48.04 ▼ -13.50% | The 5-year CRISPR Therapeutics AG Common Shares view is $73.39 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year CRISPR Therapeutics AG Common Shares view is $73.39 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $55.54 | Mid |
| Daily Change | -3.73% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 65% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $55.54 | Daily Change | -3.73% |
| Market Cap | $5.35B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.